9BN-28240-83588 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-15
Dose 1 — Pfizer-BioNTech
2021-02-05
Registered in v-safe
2021-02-05
Dose 2 — Pfizer-BioNTech
2021-02-05
Survey response — day 0, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches

Free text: Light headed at times

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-07
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Shortness of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-02-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Nausea, Rash, not including the immediate area around the injection site

Adult check-in
2021-02-10
Survey response — days 1–6 daily, dose 2
MedDRA: Urticaria — Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection site

Free text: Hives

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-12
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-19
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-26
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-05
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-12
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-07
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-06
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-11
Dose 3 — Pfizer-BioNTech
2022-02-05
Survey response — 12 months, dose 2
MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Covid, pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-10-11
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-15	Pfizer-BioNTech
2	2021-02-05	Pfizer-BioNTech
3	2021-10-11	Pfizer-BioNTech	No

Free text

Release 3 — day 0, dose 2

2021-02-05

Systemic reaction (other): Light headed at times

Release 3 — days 1–6 daily, dose 2

2021-02-07

Systemic reaction (other): Shortness of breath

Release 4 — days 1–6 daily, dose 2

2021-02-10

Systemic reaction (other): Hives

Release 11 — 12 months, dose 2

2022-02-05

Symptoms: Covid, pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Pregnancy	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Urticaria	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release